ID

27235

Description

Study ID: 101468/188 Clinical Study ID: SKF-101468/188 Study Title:A Study of the Maintained Efficacy and Safety of Ropinirole Versus Placebo in the Long Term Treatment of Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Parkinson Disease Module: Serious Adverse Experience

Keywords

Versions (1)
  1. 11/3/17 11/3/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

November 3, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GSK Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/188

English

Serious Adverse Experience

1 forms  
Serious Adverse Experience (SAE)
Description

Serious Adverse Experience (SAE)

Alias
UMLS CUI-1
C1519255
Person Reporting SAE
Description

Person Reporting SAE

Data type

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C1519255
AEGIS Number
Description

AEGIS Number

Data type

integer

Alias
UMLS CUI [1]
C0600091
Serious Adverse Experience
Description

Serious Adverse Experience

Data type

text

Alias
UMLS CUI [1]
C1519255
Reasons for considering a serious AE
Description

Reasons for considering a serious AE

Data type

integer

Alias
UMLS CUI [1]
C1519255
Onset Date and Time SAE
Description

Onset Date and Time SAE

Data type

datetime

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0808070
UMLS CUI [1,3]
C1301880
End Date and Time (if ongoing please leave blank) SAE
Description

End Date and Time SAE

Data type

datetime

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0806020
UMLS CUI [1,3]
C1522314
Outcome SAE
Description

If patient died, please complete Form D

Data type

integer

Alias
UMLS CUI [1,1]
C1705586
UMLS CUI [1,2]
C1519255
Experience Course
Description

Experience Course

Data type

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0750729
If experience course intermittent, please fill in no. of episodes
Description

Number of episodes

Data type

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C4086638
Intensity SAE
Description

Intensity SAE

Data type

integer

Alias
UMLS CUI [1,1]
C1710066
UMLS CUI [1,2]
C1519255
Action Taken with Respect to Investigational Drug
Description

Action Taken with Respect to Investigational Drug

Data type

integer

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C1519255
Did the SAE abate?
Description

Abatement

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0547047
If Investgational product was interrupted, stopped or dose reduced: Was investigational product reintroduced (or dose increased)?
Description

Reintroduction of product

Data type

boolean

Alias
UMLS CUI [1,1]
C0376495
UMLS CUI [1,2]
C0304229
UMLS CUI [2]
C1519255
If yes, did SAE recur?
Description

Recurrence of SAE

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0034897
Relationship to Investigational Drug
Description

Relationship to Investigational Drug

Data type

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0439849
The SAE is probably associated with
Description

SAE association

Data type

integer

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1710056
Please specify association
Description

SAE association

Data type

text

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1710056
Corrective Therapy SAE
Description

(If "Yes", record details in the Concomitant Medication or Medical Procedures section)

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0087111
Was patient withdrawn due to this specific SAE?
Description

Withdrawal

Data type

boolean

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C1519255
Remarks SAE
Description

Please provide a brief narrative description of the SAE, attaching extra pages eg. hospital discharge summary if necessary

Data type

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0947611
If applicable, was randomisation code broken at investigational site?
Description

randomisation code broken

Data type

boolean

Alias
UMLS CUI [1]
C0034656
UMLS CUI [2]
C1519255
Randomisation Number
Description

Randomisation Number

Data type

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
UMLS CUI [2]
C1519255
Investigator’s Signature
Description

Investigator’s Signature

Data type

text

Alias
UMLS CUI [1]
C2346576
UMLS CUI [2]
C1519255
Relevant Laboratory Data
Description

Relevant Laboratory Data

Alias
UMLS CUI-1
C0587081
UMLS CUI-2
C1519255
Test
Description

Test

Data type

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0332307
Date of test
Description

Date of test

Data type

date

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0011008
Value of test
Description

Value of test

Data type

text

Alias
UMLS CUI [1,1]
C1522609
UMLS CUI [1,2]
C0587081
Units of test
Description

Units of test

Data type

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C0587081
Normal Range of test
Description

Normal Range of test

Data type

text

Alias
UMLS CUI [1,1]
C0086715
UMLS CUI [1,2]
C0587081
Back to the top of the page

Similar models

Serious Adverse Experience

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Serious Adverse Experience (SAE)
C1519255 (UMLS CUI-1)
Person Reporting SAE
Item
Person Reporting SAE
text
C0008961 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
AEGIS Number
Item
AEGIS Number
integer
C0600091 (UMLS CUI [1])
Serious Adverse Experience
Item
Serious Adverse Experience
text
C1519255 (UMLS CUI [1])
Item
Reasons for considering a serious AE
integer
C1519255 (UMLS CUI [1])
Reasons for considering a serious AE
Code List
Reasons for considering a serious AE
CL Item
fatal (1)
CL Item
life threatening (2)
CL Item
disabling/incapacitating (3)
CL Item
results in hospitalisation (excluding elective surgery or routine clinical procedures) (4)
CL Item
hospitalisation prolonged (5)
CL Item
congenital abnormality (6)
CL Item
cancer (7)
CL Item
overdose (8)
CL Item
Investigator considers serious or a significant hazard, contraindication, side effect or precaution (9)
Onset Date and Time SAE
Item
Onset Date and Time SAE
datetime
C1519255 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,3])
End Date and Time SAE
Item
End Date and Time (if ongoing please leave blank) SAE
datetime
C1519255 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,3])
Item
Outcome SAE
integer
C1705586 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Outcome
Code List
Outcome SAE
CL Item
Resolved (1)
CL Item
Ongoing (2)
CL Item
Died (3)
Item
Experience Course
integer
C1519255 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Experience Course
Code List
Experience Course
CL Item
Intermittend -> Please fill in No. of episodes below (1)
CL Item
Constant (2)
Number of episodes
Item
If experience course intermittent, please fill in no. of episodes
integer
C1519255 (UMLS CUI [1,1])
C4086638 (UMLS CUI [1,2])
Item
Intensity SAE
integer
C1710066 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Intensity
Code List
Intensity SAE
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Action Taken with Respect to Investigational Drug
integer
C2826626 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Action Taken with Respect to Investigational Drug
Code List
Action Taken with Respect to Investigational Drug
CL Item
None (1)
CL Item
Dose reduced (2)
CL Item
Dose increased  (3)
CL Item
Drug interrupted restarted  (4)
CL Item
Drug stopped (5)
Abatement
Item
Did the SAE abate?
boolean
C1519255 (UMLS CUI [1,1])
C0547047 (UMLS CUI [1,2])
Reintroduction of product
Item
If Investgational product was interrupted, stopped or dose reduced: Was investigational product reintroduced (or dose increased)?
boolean
C0376495 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Recurrence of SAE
Item
If yes, did SAE recur?
boolean
C1519255 (UMLS CUI [1,1])
C0034897 (UMLS CUI [1,2])
Item
Relationship to Investigational Drug
integer
C1519255 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
Relationship to Investigational Drug
Code List
Relationship to Investigational Drug
CL Item
Related (1)
CL Item
Possibly related (2)
CL Item
Probably unrelated (3)
CL Item
Unrelated (4)
Item
The SAE is probably associated with
integer
C0085978 (UMLS CUI [1,1])
C1710056 (UMLS CUI [1,2])
Assessment
Code List
The SAE is probably associated with
CL Item
Protocol design or procedures (but not to study drug) -> please specify below (1)
CL Item
Another condition (e.g condition under study, intercurrent illness) -> please specify below (2)
CL Item
Another drug (please specify below) (3)
SAE association
Item
Please specify association
text
C0085978 (UMLS CUI [1,1])
C1710056 (UMLS CUI [1,2])
Corrective Therapy SAE
Item
Corrective Therapy SAE
boolean
C1519255 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Withdrawal
Item
Was patient withdrawn due to this specific SAE?
boolean
C0422727 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Remarks SAE
Item
Remarks SAE
text
C1519255 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
randomisation code broken
Item
If applicable, was randomisation code broken at investigational site?
boolean
C0034656 (UMLS CUI [1])
C1519255 (UMLS CUI [2])
Randomisation Number
Item
Randomisation Number
integer
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Investigator’s Signature
Item
Investigator’s Signature
text
C2346576 (UMLS CUI [1])
C1519255 (UMLS CUI [2])
Item Group
Relevant Laboratory Data
C0587081 (UMLS CUI-1)
C1519255 (UMLS CUI-2)
Test
Item
Test
text
C0022885 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Date of test
Item
Date of test
date
C0022885 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Value of test
Item
Value of test
text
C1522609 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Units of test
Item
Units of test
text
C1519795 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Normal Range of test
Item
Normal Range of test
text
C0086715 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial